Meta facebook tracking pixel

Listen Now

Topics Covered

  • What is Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation?
  • Understanding How GVHD Develops, Including Finding GVHD Early, in the Context of COVID-19 & Its Variants
  • Common Signs and Symptoms of GVHD
  • Types of GVHD: Chronic and Acute
  • Current Standard of Care for Managing GVHD
  • New & Promising Treatment Approaches for GVHD
  • Clinical Trials: How Research Increases Treatment Options
  • The Increasing Role of Telehealth/Telemedicine Appointments
  • Key Questions to Ask Your Health Care Team about Quality-of-Life Concerns
  • Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology, Prepared List of Questions, Follow-Up Care & Discussion of OpenNotes
  • Questions for Our Panel of Experts

Our Panel of Experts

Presenter

Samer Al-Homsi, MD, MBA

Professor of Clinical Medicine, New York University, Director of Blood and Marrow Transplantation, Perlmutter Cancer Center, NYU Langone Health

Presenter

Zachariah DeFilipp, MD

Director of BMT Clinical Research, Hematopoietic Cell Transplant & Cellular Therapy Program, Massachusetts General Hospital, Assistant Professor in Medicine, Harvard Medical School

Presenter

Nandita Khera, MD, MPH

Consultant, Division of Hematology/Oncology Department of Internal Medicine Associate Professor of Medicine College of Medicine, Mayo Clinic

Presenter

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Senior Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop Download button

Workshop Date

This workshop was originally recorded on April 28, 2022.

Search by:

Diagnosis

Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top

Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.